739102
Last Update Posted: 2014-04-17
Recruiting has ended
All Genders accepted | 30 Years + |
250 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery Disease
A multi-center, non-randomized, single-arm, prospective trial evaluating the safety and effectiveness of the S.M.A.R.T.™ Nitinol Stent System implantation in approximately 250 patients with obstructive superficial femoral artery disease.
Eligibility
Relevant conditions:
Superficial Femoral Artery Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov